Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 139, Issue 3, Pages 664-672
Publisher
Wiley
Online
2016-03-19
DOI
10.1002/ijc.30085
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?
- (2015) Casey J Rowe et al. AUSTRALASIAN JOURNAL OF DERMATOLOGY
- Prognostic survival model for people diagnosed with invasive cutaneous melanoma
- (2015) Peter D Baade et al. BMC CANCER
- No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial-I final report
- (2015) M. Sladden et al. BRITISH JOURNAL OF DERMATOLOGY
- Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia
- (2015) B. Mark Smithers et al. JOURNAL OF SURGICAL ONCOLOGY
- Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy
- (2015) Pedram Gerami et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy
- (2014) Kiarash Khosrotehrani et al. EUROPEAN JOURNAL OF CANCER
- Sentinel lymph node biopsy in melanoma: controversies and current guidelines
- (2014) Alison B Durham et al. Future Oncology
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
- (2014) Donald L. Morton et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAF Mutation, NRAS Mutation, and the Absence of an Immune-Related Expressed Gene Profile Predict Poor Outcome in Patients with Stage III Melanoma
- (2012) Graham J. Mann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
- (2011) Augustinus P.T. van der Ploeg et al. JOURNAL OF CLINICAL ONCOLOGY
- Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
- (2011) Sarah-Jane Schramm et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Melanoma Prognosis: A REMARK-Based Systematic Review and Bioinformatic Analysis of Immunohistochemical and Gene Microarray Studies
- (2011) S.-J. Schramm et al. MOLECULAR CANCER THERAPEUTICS
- Melanoma epidemic: a midsummer night’s dream?
- (2009) N.J. Levell et al. BRITISH JOURNAL OF DERMATOLOGY
- Macrophage Markers in Serum and Tumor Have Prognostic Impact in American Joint Committee on Cancer Stage I/II Melanoma
- (2009) Trine O. Jensen et al. JOURNAL OF CLINICAL ONCOLOGY
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
- (2009) Bonnie E. Gould Rothberg et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search